How many insider trades does FilingIQ track for CRBP?

FilingIQ tracks 260 Form 4 insider transactions for CRBP (Corbus Pharmaceuticals Holdings, Inc.), covering filings from Dec 17, 2014 onwards. 2 of those were filed in the last 90 days.

Are CRBP insiders net buyers or net sellers?

Across the full Form 4 history for CRBP, 130 transactions (50%) were open-market purchases and 33 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CRBP insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CRBP in?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $136.17M.

CRBP insider trading

NasdaqCM Healthcare

Corbus Pharmaceuticals Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

260

Last 90 days

Buys / sells

50% / 13%

Market cap

$136.17M

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

Company website: www.corbuspharma.com

CRBP insider activity at a glance

FilingIQ has scored 260 insider transactions for CRBP since Dec 17, 2014. The most recent filing in our index is dated Mar 2, 2026.

Across the full history, 130 open-market purchases and 33 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CRBP insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CRBP trades on FilingIQ Raw filings on SEC EDGAR

Latest CRBP Form 4 filings

Cohen Yuval Chief Executive Officer

S Feb 14, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding CRBP

Ikarian Capital, LLC

$21.95M · 2.4% of AUM

STEMPOINT CAPITAL LP

$4.59M · 1.3% of AUM

Frequently asked

How many insider trades does FilingIQ track for CRBP?: FilingIQ tracks 260 Form 4 insider transactions for CRBP (Corbus Pharmaceuticals Holdings, Inc.), covering filings from Dec 17, 2014 onwards. 2 of those were filed in the last 90 days.
Are CRBP insiders net buyers or net sellers?: Across the full Form 4 history for CRBP, 130 transactions (50%) were open-market purchases and 33 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CRBP insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CRBP in?: Corbus Pharmaceuticals Holdings, Inc. (CRBP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $136.17M.

Methodology & sources

Every CRBP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.